INTRODUCTION
============

Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus initially identified in Wuhan, China, in December 2019 ([@B1]). By March 11, 2020, the pathogen had been rapidly spread to 113 countries worldwide ([@B2]). COVID-19 has typical manifestations of acute pneumonia and severe complications such as acute respiratory distress syndrome, and its mortality rate was estimated to be approximately 2% ([@B2][@B3][@B4]). Since it is a highly infectious disease and transmission by asymptomatic patients has been proven ([@B5]), early detection and diagnosis are of significant importance in disease control and treatment. Radiological characteristics provide important evidence for the clinical diagnosis of COVID-19. According to previous studies ([@B6][@B7][@B8][@B9][@B10][@B11]), bilateral and peripheral predominant ground-glass opacity (GGO) or mixed GGO and consolidation with signs such as crazy paving, air bronchogram, and interstitial thickening were common findings in adult patients diagnosed with COVID-19. However, information regarding pediatric clinical and radiological features of COVID-19 is insufficient ([@B12][@B13][@B14][@B15]). This study aimed to describe a pediatric case series diagnosed with COVID-19 in detail to illustrate early computed tomography (CT) findings.

MATERIALS AND METHODS
=====================

The study was approved by the Institutional Review Board of Zhongnan Hospital of Wuhan University (approval number 2020004). The requirement for written informed consent was waived.

Patients
--------

A total of 1574 patients were diagnosed with COVID-19 by reverse transcription-polymerase chain reaction (RT-PCR) tests in Zhongnan Hospital of Wuhan University from January 20, 2020 to February 28, 2020. Among all confirmed cases, six were pediatric patients, including one infant and five children aged less than 14 years. After excluding one child and one infant with no radiological examination, a total of four children (two boys and two girls; age range, 7--13 years) were included in the current study.

Clinical Information Collection
-------------------------------

Data regarding demographics, laboratory findings, treatment, and prognosis were collected from the patients\' electronic medical records by two independent researchers. Familial clustering information was collected by direct communication with patients and their families. Disease severity was evaluated according to the 7th edition of the diagnosis and treatment guidelines of COVID-19 pneumonia in China ([@B16]).

CT Protocol
-----------

CT scan (Discovery, GE Medical Systems, Milwaukee, USA) was performed on patients in the supine position under free breathing with the following parameters: 120 kV and automatic tube current (100--150 mA), 1-mm slice thickness with 1-mm gap, lung window setting with window center at −700 HU and window width at 1500 HU, and mediastinal window setting with window center at 40 HU and window width at 400 HU.

Image Analysis
--------------

CT features were evaluated by two experienced radiologists who were blinded to the RT-PCR results. The presence of specific CT signs was recorded including GGO, consolidation, mixed GGO and consolidation, crazy paving pattern, air bronchogram, interstitial thickening, parenchymal band, reticular pattern, and lymphadenopathy. Other signs including cystic changes, bronchiolectasis, tree-in-bud, halo sign, calcification, and pleural effusion were also evaluated. Lesion distribution was categorized as peripheral (outer 1/3 of the lung), central (inner 2/3 of the lung), or both. Lesion size was recorded as small (diameter \< 1 cm), moderate (1 cm ≤ diameter ≤ 3 cm), or large (diameter \> 3 cm). Infected lobes and bilateral or unilateral lung involvement were also recorded.

RESULTS
=======

Clinical Characteristics
------------------------

The four children were diagnosed with COVID-19 after close contact with infected family members. They were asymptomatic throughout the disease course (range, 7--15 days). Their blood cell counts and procalcitonin and C-reactive protein levels remained within the normal limits. Coinfection was not observed. A significant increase in alanine aminotransferase and aspartate aminotransferase levels was observed in one child without evidence for hepatitis. All reported children were discharged after obtaining at least two consecutive negative RT-PCR test results (three repeats for the two younger children). The time interval from confirmation to first negative RT-PCR result varied from 2 to 12 days ([Table 1](#T1){ref-type="table"}).

CT Features on Admission
------------------------

Three of the four pediatric patients showed abnormalities on thin-section CT scans, and the fourth patient had a negative CT scan result. Unilateral lung involvement was observed in two patients, and only one child had bilateral lung infection. In total, five lesions were identified in three patients ([Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). All lesions were small (diameter \< 1 cm) with peripheral distribution, and they were located in the lower lobes with predilection of the left lower lobe (n = 4).

In a per-lesion analysis, GGO (n = 4) was more common, followed by consolidation (n = 1). Margins of all lesions were ill-defined. The halo sign could be observed surrounding the consolidation ([Fig. 1](#F1){ref-type="fig"}). Of the four GGO lesions, one was mixed GGO or part-solid GGO ([Fig. 2](#F2){ref-type="fig"}), while the other lesions (n = 3) were pure GGO. Delicate interstitial thickening was observed in one pure GGO lesion ([Fig. 3](#F3){ref-type="fig"}). Crazy paving pattern or air bronchogram sign was not observed. Signs including cystic changes, bronchiolectasis, reticular pattern, tree-in-bud, calcification, lymphadenopathy, and pleural effusion were not observed.

CT Changes in Follow-Up Imaging
-------------------------------

Regarding disease treatment, vitamin C was administered to the two younger patients, while arbidol was administered to the other two older patients. The follow-up CT imaging after treatment revealed that all the pulmonary exudative lesions were substantially resolved.

DISCUSSION
==========

A low percentage (0.4%, 6 of the 1574 patients) of pediatric patients aged less than 14 years was diagnosed with COVID-19 in our center, which was consistent with the results previously reported by Guan et al. ([@B17]) (0.9%). According to previous studies ([@B12][@B13][@B14][@B15][@B17]), most pediatric cases of COVID-19 were mild and showed symptoms similar to those of adult cases. The reported four patients were subclinical cases and had good prognoses after a disease course ranging from 7 to 15 days. Notably, for Patient 4 with one lesion on CT images and no new lesion arising during treatment, a significantly longer time interval was observed from confirmation to first negative RT-PCR (12 days) compared with the other three patients. This suggested that the duration of viral shedding might not be associated with disease severity evaluated with CT scan.

Regarding laboratory findings, lymphopenia or leucopenia was not observed, although they were common findings in most adult patients diagnosed with COVID-19 ([@B3][@B17]). A remarkable increase in procalcitonin levels and a significant proportion of coinfection were observed among pediatric patients according to Xia et al.\'s study ([@B13]), and this finding was not observed in the current four patients. One child had hepatic dysfunction upon admission and recovered quickly after treatment. After ruling out hepatitis, it was considered possible that the hepatic damage was caused by COVID-19, which had been previously reported in adult patients ([@B18]).

Considering that RT-PCR test was time consuming and showed high false-negative rate in China ([@B19]), radiological findings were considered important in infection detection and disease control. Although chest radiography is a regular examination, it was not recommended for COVID-19 due to its low sensitivity and nonspecific manifestation, which had been reported in several studies ([@B10][@B15]). As most pediatric patients were mild or moderate cases of COVID-19, the rate of misdiagnosis by radiography might be higher for children than for adults, leading to delayed isolation and treatment for at least a proportion of pediatric patients with initial false-negative RT-PCR results. Compared to radiography, thin-section CT was more sensitive to subtle changes in early infection and was recommended by the guidelines for imaging diagnosis of COVID-19 in China ([@B20]).

In adult patients, bilateral lung involvement was frequently observed in most patients; peripherally located GGO or mixed GGO and consolidation in CT images were typical findings, with or without crazy paving, interstitial thickening, or air bronchogram signs ([@B7][@B9][@B10][@B11]). These manifestations were similar but milder in pediatric patients. In the current study, unilateral involvement was observed in two of the four patients. Predilection of peripheral or subpleural distribution could be observed, and the lower lobes were more likely to be infected, which was observed in a previous study ([@B12]) and in adult patients ([@B19]). A majority of patients in this study showed small patches of GGO with ill-defined borders, and consolidation surrounded by the halo sign was not as common as had been reported previously ([@B4]). One possible explanation is that consolidation tends to develop in the progressive stage ([@B7][@B21]). CT signs such as crazy paving, interstitial thickening, and air bronchogram were infrequently observed due to the relatively smaller lesions in children (diameter \< 1 cm). Reticular pattern, parenchymal band, pleural changes, lymphadenopathy, and pleural effusion were not observed in the current study.

All four children reported familial cluster transmission, which was consistent with the reported transmission pattern among infants ([@B22]). Thus, adult family members with high risk factors of COVID-19 infection should pay special attention when in direct contact with children. Additionally, since some pediatric infections have an asymptomatic or mild manifestation, attention should be paid to potential transmission by such cases as asymptomatic carrier transmission has already been proven ([@B5]).

The current study had a small sample size, which is a limitation. Hence, further investigation with a large cohort is required to understand the full disease spectrum among children with COVID-19. Additionally, radiography findings from the four children were not available because CT was the recommended examination for both adult and pediatric COVID-19 patients according to the guidelines for imaging diagnosis of COVID-19 in China ([@B20]). However, considering that pediatric COVID-19 tends to be mild and different from adult cases, the recommendation of CT as a routine radiological examination for pediatric patients awaits further evidence to carefully weigh the benefits and risks of CT.

In summary, a pediatric case series of COVID-19 was described. Although similar to adult patients, pediatric patients tended to experience mild manifestations of COVID-19. Regarding CT features, small patches of GGO with subpleural distribution and unilateral lung involvement were common findings in pediatric patients in the early stage of the disease. Consolidation surrounded by the halo sign could also be observed. Margins of lesions were ill-defined. Lower lobes were predominantly infected. All exudative lesions were substantially resolved after treatment, and patients had good prognoses. Additionally, familial cluster was the main transmission pattern of these pediatric infections. Potential asymptomatic carrier transmission by pediatric patients should be further studied.
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![7-year-old twin girl diagnosed with COVID-19.\
**A.** CT scan on admission (day 1) showed subpleural ground-glass opacity and consolidation in left lower lobe (arrows). **B.** On discharge (day 13), acute exudative lesions were substantially resolved after treatment. COVID-19 = coronavirus disease 2019, CT = computed tomography](kjr-21-919-g001){#F1}

![12-year-old girl diagnosed with COVID-19.\
Small patches of ground-glass opacity were observed on CT scan, with subpleural distribution and bilateral lung involvement (arrows).](kjr-21-919-g002){#F2}

![13-year-old boy diagnosed with COVID-19.\
**A.** Patch of ground-glass opacity can be observed in left lower lobe (arrow). **B.** Delicate interstitial thickening was observed in zoom-in image (arrow) without formation of crazy paving pattern.](kjr-21-919-g003){#F3}

###### Clinical and CT Features

![](kjr-21-919-i001)

  Characteristics                                                  Case 1      Case 2       Case 3       Case 4
  ---------------------------------------------------------------- ----------- ------------ ------------ ------------
  Demographics                                                                                           
   Age (years)                                                     7           7            12           13
   Sex                                                             Male        Female       Female       Male
  Symptoms at onset                                                None        None         None         None
  Symptoms during whole disease course                             None        None         None         None
  Epidemiologic history                                                                                  
   Family members infected                                         3           3            1            1
  Severity of disease on admission                                 Mild        Mild         Mild         Mild
  Laboratory findings                                                                                    
   White blood cell count (× 10^9^/L)                              6.86        4.79         6.52         4.60
   Neutrophil count (× 10^9^/L)                                    1.47        2.23         3.48         2.28
   Lymphocyte count (× 10^9^/L)                                    4.66        2.18         2.33         1.85
   Alanine aminotransferase (U/L)                                  16          520          15           39
   Aspartate aminotransferase (U/L)                                24          439          16           27
   Procalcitonin (mg/L)                                            \< 0.05     \< 0.05      \< 0.05      \< 0.05
   C-reactive protein (mg/L)                                       0.54        0.54         1.70         1.30
   Co-infection                                                    None        None         None         None
  CT features on admission                                                                               
   GGO                                                             None        Presence     Presence     Presence
   Consolidation                                                   None        Presence     None         None
   Lesion distribution                                             None        Peripheral   Peripheral   Peripheral
   Lesion size                                                     None        Small        Small        Small
   Infected lobe                                                   None        Lower lobe   Lower lobe   Lower lobe
   Unilateral or bilateral lung involvement                        None        Unilateral   Bilateral    Unilateral
  Treatment                                                                                              
   Intensive care unit                                             No          No           No           No
   Severe complications                                            No          No           No           No
   Medication                                                      Vitamin C   Vitamin C    Arbidol      Arbidol
   Time from confirmation to first negative RT-PCR result (days)   2           4            3            12
  Time from confirmation to discharge (days)                       13          13           7            15

CT = computed tomography, GGO = ground glass opacity, RT-PCR = reverse transcription-polymerase chain reaction
